• Gyrodyne estimates net assets in liquidation at $10.75 per share as of September 30, 2026, down from $12.30 on June 30.
• The preliminary $3.4 million decline primarily reflects a lower estimated Flowerfield sale value, net of termination costs, under a potential state sale.
• Negotiations with New York State contemplate terminating the B2K sale agreement, contingent on completing the state transaction; neither agreement is definitive.
• A state sale could close in the second half of 2027; the B2K transaction risks delays beyond 2028 or failing entirely.
• Liquidation remains targeted for completion by December 31, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gyrodyne LLC published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-035148), on November 05, 2026, and is solely responsible for the information contained therein.